Skip to main content

Substance Abuse clinical trials at UCLA

10 in progress, 5 open to eligible people

Showing trials for
  • Age-dependent Effects of Smoked and Oral Delta-9-THC

    open to eligible people ages 18-65

    This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.

    Los Angeles, California

  • Cannabis Effects as a Function of Sex

    open to eligible people ages 21-55

    The purpose of this research is to assess the impact of cannabis on the analgesic and abuse-related effects between men and women

    Los Angeles, California

  • THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy

    open to eligible people ages 21-55

    The purpose of this research is to assess the impact of CBD on the effects of THC.

    Los Angeles, California

  • California MEPS Hub

    open to eligible males ages 18-59

    The California Hub for HIV/SUD Prevention Research with Reentry Populations addresses the question: "Can the evidence-based MEPS intervention be adapted and implemented at a range of organizations to effectively serve a wider range of clients?" The Mobile Enhanced Prevention Support (MEPS) intervention was originally implemented in Los Angeles County and was proven successful in promoting biomedical HIV prevention (PrEP) uptake and preventative screenings in people who used drugs who recently left incarceration. MEPS is an evidence-based intervention for people with substance use disorders (SUD) that incorporates a client-centered planning session, including trained peer mentors, service utilization incentives, and a mobile application (GeoPass). The study includes a randomized controlled trial (RCT) across three community partners located in Riverside and Alameda Counties. At least 300 people will be enrolled in these three counties; the first 200 will be randomized to either receive the intervention or usual care, with the final 100 all receiving the intervention. The primary implementation outcome for the study involves using an implementation science framework and assessment tools to examine MEPS's implementation. Key outcomes include how well the implementation strategies used support intervention enrollment and retention, integration with existing services in each partnering community agency, and perceived intervention acceptability, feasibility, appropriateness, and maintenance at 6- and 12-months. The primary effectiveness outcome for the study is an increase in HIV testing, PrEP uptake and adherence, and SUD service utilization at 6 months and 12 months in the MEPS compared to the usual care group. Secondary effectiveness outcomes include frequency of service use for SUDs, hepatitis C virus testing, and linkage to care for those who test positive for HIV or hepatitis C.

    Riverside, California and other locations

  • MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

    open to eligible people ages 18 years and up

    This randomized, double-blind, single-site phase II 2-arm study will investigate the safety and preliminary efficacy of MDMA-assisted therapy compared with low dose d-amphetamine-assisted therapy on the severity of PTSD symptoms in participants aged 18 years and older with PTSD of at least moderate severity.

    Los Angeles, California and other locations

  • AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)

    Sorry, in progress, not accepting new patients

    This study will assess the analgesic, appetite-stimulating, and subjective effects of cannabigerol (CBG) alone and in combination with THC.

    Los Angeles, California

  • Oral THC and CBD in Men and Women

    Sorry, not yet accepting patients

    The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.

    Los Angeles, California

  • Analgesic and Subjective Effects of Terpenes

    Sorry, in progress, not accepting new patients

    The purpose of this research is to assess the analgesic and subjective effects of terpenes administered alone and in combination of THC.

    Los Angeles, California

  • Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)

    Sorry, in progress, not accepting new patients

    The purpose of this trial is to test the efficacy of a collaborative care intervention to address opioid- and/or stimulant-involved polysubstance use in adult primary care patients with moderate to severe substance use disorders (SUD). The primary aims are to reduce days of opioid use (illicit or nonmedical opioid use), days of illicit stimulant use (cocaine, methamphetamine), and days of heavy alcohol use.

    Torrance, California and other locations

  • Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing

    Sorry, not yet accepting patients

    The Department of Housing and Urban Development-VA Supportive Housing (HUD-VASH) Program provides subsidized permanent housing with case management to homeless-experienced Veterans (HEVs). Up to 40% of Veterans exit HUD-VASH within two years of attaining housing; substance use disorders (SUDs) are one of the largest causes of returns to homelessness for HEVs. CARE-VASH QUERI proposes to implement and evaluate two evidence-based SUD services - Medications for addiction treatment (MAT) and cognitive behavioral therapy for SUDs (CBT-SUD) - among Veterans in HUD-VASH.

    West Los Angeles, California

Our lead scientists for Substance Abuse research studies include .

Last updated: